In this cancer type, increased IFIT3 expression promoted tumor growth, invasion, metastasis, EMT and a pro-inflammatory tumor microenvironment [16,68], as well as resistance to chemotherapy and targeted therapy [28,29,30]. Here, IFIT3 is linked to cancer.